Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent<i>Clostridium difficile</i>Infection
Emily G. McDonald(McGill University Health Centre), Todd C. Lee(McGill University Health Centre), Jonathon Milligan(University of Toronto), Charles Frenette(McGill University Health Centre)
Cited by 212
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|287
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
|Open Forum Infectious Diseases|2020|215